These sessions are organised during the yearly meeting of the ESH and focus on problems in hypertensive patients seen in daily practice. The talks are given by experts and the material is provided in an excellent educational format with many take-home messages.
29th European Meeting on Hypertension and Cardiovascular Protection
June 21-24, 2019 – Milan, Italy
Teaching Seminar – Session 1
- New blood pressure guidelines in children and adolescent
E. Lurbe (Valencia, Spain) - Antihypertensive drugs and the risk of cancer
A. Douros (Berlin, Germany) - Air Pollution and hypertension
P. van de Borne (Brussels, Belgium) - Microalbuminuria: shall we use it in routine practice? A debate
Teaching Seminar – Session 2
- Hypertension in different categories: is drug treatment different?
Antihypertensive treatment in patients with heart failure
M. Volpe (Rome, Italy) - The pathophysiology and management of hypertension in black populations
A. Schutte (Johannesburg, South Africa) - Microcirculation and retinal changes in hypertension
D. Rizzoni (Brescia, Italy) - Primary aldosteronism: new therapeutic approaches
B. Williams (London, UK) - How to manage BP before, during, after surgery?
A.J. Manolis (Athens, Greece)
Teaching Seminar – Session 3
- How to manage masked hypertension
G. Parati (Milan, Italy) - The challenge of vaccination against hypertension
T. Unger (Maastricht, The Netherlands)
28th European Meeting on Hypertension and Cardiovascular Protection
June 8-11, 2018 – Barcellona, Spain
Teaching Seminar – Session 1
- Hypertension in chronic pulmonary disease (COPD)
C. Farsang (Budapest, Hungary) - Management of existing Hypertension during pregnancy
R.Cifková (Prague, Czech Republic) - Do we need an albuminuria check in all new hypertensive patients?
J.M. PascualIzuel (Valencia, Spain) - Any hope to detect new mechanisms leading to hypertension?
H.A. Struijer-Boudier (Maastricht, The Netherlands)
Teaching Seminar – Session 2
- Renal nerve ablation: do we have the final conclusion?
R.E. Schmieder (Erlangen, Germany) - Do we need an echocardiogram in all “new” hypertensive patients?
T. de Backer (Ghent, Belgium) - Should we measure pulse wave velocity in all hypertensive patients?
C. Vlachopoulos (Athens, Greece) - Clinical value of intima-media thickness
S. Laurent (Paris, France)
Teaching Seminar – Session 3
- Emergencies in hypertension
M.L. Muiesan (Brescia, Italy) - Management of high blood pressure in acute stroke
D. Gasecki (Gdansk, Poland) - Is telephone connection helpful in the management of hypertension?
G. Parati (Milan, Italy)
27th European Meeting on Hypertension and Cardiovascular Protection
June 16-19, 2017 – Milan, Italy
Teaching Seminar – Session 1
- Effect of anti-cancer therapy on blood pressure and other cardiovascular parameters
H.A.J. Struijker-Boudier (Maastricht, The Netherlands) - New trends in treatment and prevention: from combination therapy to the polypill
T. Kahan (Stockholm, Sweden) - Is hypertension linked to our genes? Status 2017
M.J. Caulfield (London, United Kingdom) - White coat hypertension: still innocent? Role of therapy?
G. Grassi (Milan, Italy)
Teaching Seminar – Session 2
- Is antihypertensive treatment cost-effective?
R. Kreutz (Berlin, Germany) - How useful is the concept of “total” cardiovascular risk hypertension
M. Bochud (Lausanne, Switzerland) - What about high BP at the time of a cerebrovascular event?
A. Coca (Barcelona, Spain) - Low blood pressure: good and bad! What is the problem?
D.L. Clement (Ghent, Belgium)
Teaching Seminar – Session 3
- Why is blood pressure still insufficiently controlled in Europe? What can be done?
B. Jelakovic (Zagreb, Croatia) - Adherence to antihypertensive treatment
M. Azizi (Paris, France) - Is sport dangerous in hypertensive patients?
C. Giannattasio (Milan, Italy) - Uric Aid and hypertension: What is the problem?
C. Borghi (Bologna, Italy)
26th European Meeting on Hypertension and Cardiovascular Protection
June 10-13, 2016 – Paris, France
Teaching Session 1 – Management of Hypertension 1
- Should we give statins to all hypertensive patients?
H.A.J. Struijker-Boudier (Maastricht, Netherlands) - How far to lower BP? Revisiting the ESH-ESC Guidelines after SPRINT
R.H. Fagard (Leuven, Belgium) - Is BP control different in women compared to men?
A.O. Konradi (Saint-Petersburg, Russia) - Central BP: a better means to obtain goal blood pressure?
J.K. Cruickshank (London, United Kingdom)
Teaching Sesison 2 – Management of Hypertension 2
- BP Variability: how to measure? How to treat?
G. Parati (Milan, Italy) - Salt and hypertension: where are we?
D.L. Clement (Ghent, Belgium) - Arterial damage in hypertension: which parameter should be investigated in all patients and how?
C. Vlachopoulos (Athens, Greece) - Are there new antihypertensive drugs coming?
S. Laurent (Paris, France)
Teaching Session 3 – Management of Hypertension 3
- Organ damage and risk factors: can we afford to explore them all?
M.H. Olsen (Glostrup, Denmark) - Parameters of organ damage in hypertension: do they all react similarly to antihypertensive treatment?
E. Agabiti Rosei (Brescia, Italy) - Renal nerve ablation: is the last word said?
R.E. Schmieder (Erlangen, Germany) - Hypertension in surgical patients: how to control before, during and immediately after surgery?
H. Bouaziz (Nancy, France)
25th European Meeting on Hypertension and Cardiovascular Protection
June 12-15, 2015 – Milan, Italy
Teaching Session 1 – Management of hypertension. In Memoriam of Pieter A. van Zwieten
- How to detect and treat hyperaldosteronism
G.P. Rossi (Padua, Italy) - The pros and cons of combination therapy in hypertension
H.A. Struijker-Boudier (Maastricht, Netherlands) - The sympathetic system and hypertension
G. Grassi (Milan, Italy) - Blood pressure lowering drugs: are all equal?
A. Zanchetti (Milan, Italy)
Teaching Session 2 – Management of hypertension in particular conditions – Part I
- Dietary aspects in hypertension
C. Ferri (L’Aquila, Italy) - How to treat the overstressed hypertensive patient
P. van de Borne (Brussels, Belgium) - Management of hypertension in patients with aortic stenosis-before, during and after valve replacement
K. Wachtell (Copenhagen, Denmark) - Management of hypertension in chronic pulmonary disease
C. Farsang (Budapest, Hungary)
Teaching Session 3 – Management of hypertension in particular conditions – Part II
- Treatment of hypertension emergencies
A.H. van den Meiracker (Rotterdam, Netherlands) - The diabetic kidney in hypertension
P. Plouin (Paris, France) - Renal artery stenosis treatment
P.W. de Leeuw (Maastricht, Netherlands) - Management of hypertension in carotid artery disease
D.L. Clement (Ghent, Belgium)
Joint Meeting ESH-ISH Athens 2014
June 13-16, 2014 – Athens, Greece
Teaching Session 1 – Interventions in hypertension
- Baroreflex stimulation in resistant hypertension
P. W. de Leeuw (Maastricht, Netherlands) - Renal nerve ablation
R.E. Schmieder (Erlangen, Germany) - Is PTA stenting better than medical treatment in renal stenosis?
P.F. Plouin (Paris, France) - Is there need for special blood pressure management before interventions?
C. Tsioufis (Athens, Greece)
Teaching Session 2 – Management of hypertension
- A difficult clinical case with resistant hypertension: how to manage?
S. Erdine (Istanbul, Turkey) - How to look for secondary hypertension in children?
J. Redon (Valencia, Spain) - What is the actual goal pressure in treated hypertension?
P.M. Nilsson (Malmö, Sweden) - Dementia and hypertension
A. Coca (Barcelona, Spain)
Teaching Session 3 – Particular questions
- Shall we prefer central blood pressure above peripheral pressure in hypertensive patients?
S. Laurent (Paris, France) - Salt and hypertension
M. Burnier (Lausanne, Switzerland) - What is new on ABPM and home pressure in the 2014 practice guidelines
M.G. Myers (Toronto, Canada) - Insufficiente blood pressure control: how to improve?
D.L. Clement (Ghent, Belgium)
23rd European Meeting on Hypertension and Cardiovascular Protection
June 14-17, 2013 – Milan, Italy
Teaching Session 1 – Dedicated to the memory of Wolfgang Kiowski
- Introduction
A.M. Heagerty (Manchester, United Kingdom) - Wolfgang Kiowski over the years
S. Julius (Ann Arbor, USA) - Approach to coronary artery disease in hypertension
S.E. Kjeldsen (Oslo, Norway) - Sexual dysfunction and hypertension
M. Viigimaa (Tallinn, Estonia) - Arrhythmias in hypertension
A.J. Manolis (Athens, Greece)
Teaching Session 2 – New insight in the management of hypertension
- Treating obesity in hypertension: lifestyle changes, drugs and surgery
J. Jordan (Hannover, Germany) - Management of sleep apnoea
K. Narkiewicz (Gdansk, Poland) - Pheochromocytoma – An update of diagnosis and treatment including genetic profiling
C. Farsang (Budapest, Hungary) - Side effects of antihypertensive drugs and problems with combination therapy
M.L. Muiesan (Brescia, Italy)
Teaching Session 3 – Daily life in hypertension
- Modern treatment of hypertension emergencies
A.F. van den Meiracker (Rotterdam, Netherlands) - Treating blood pressure above 80 years of age
A. Benetos (Nancy, France) - Hypertension in systemic diseases
J. Redon (Valencia, Spain) - Peripheral artery disease in hypertension
D.L. Clement (Ghent, Belgium)
22nd European Meeting on Hypertension and Cardiovascular Protection
April 26-29, 2012 – London, U.K.
Teaching Session 1: Hypertension Related Problems: Their Management and Future Prospectives
- Hypertension and Heart Failure: what drugs to choose?
E. Agabiti Rosei (Brescia, Italy) - What is new in the management of hypertension in pregnancy
R. Cifková (Prague, Czech Republic) - Where is the hypertension research going in 2012?
H. Haller (Hannover, Germany)
Teaching Session 2: Concomitant Questions in the Treatment of Hypertension
- New developments in the field of renin and aldosterone antagonists
M. Burnier (Lausanne, Switzerland) - Renovascular Hypertension 2012: Diagnosis and treatment
P.F. Plouin (Paris, France) - Renal Denervation: a clinician’s standpoint
D.L. Clement (Ghent, Belgium)
Teaching Session 3: New Ideas on the Use of Antihypertensive Agents
- How useful was the discovery of the human genome for the management of hypertension
A.F. Dominiczak (Glasgow, United Kingdon) - Metabolic aspects of hypertensive drugs
H.A. Struijker-Boudier (Maastricht, Netherlands) - Hypertension in children and adolescents
E. Lurbe (Valencia, Spain)
21th European Meeting on Hypertension and Cardiovascular Protection
June 17-20, 2011 – Milan, Italy
Teaching Session 1: Risk factor control
- Diabetes
P.M. Nilsson (Malmö, Sweden) - Obesity and other metabolic factors
M.H. Olsen (Odense, Denmark) - Stress: a risk for cardiovascular diseases?P. van de Borne (Brussels, Belgium)
- Home Blood Pressure. New ESH guidelines
G. Parati (Milan, Italy)
Teaching Session 2: Hypertension related problems and their management
- Erectile dysfunction
W. Kiowski (Zürich, Switzerland) - Erectile dysfunction – Therapeutic agents: Bad and Good
P.A. van Zwieten (Amsterdam, Netherlands) - Sport and hypertension
C. Giannattasio (Milan, Italy) - Blood pressure variability: a new life?
D.L. Clement (Ghent, Belgium) - Statins and hypertension: to be given to all patients?
H.A. Struijker-Boudier (Maastricht, Netherlands)
Teaching Session 3: Treatment issues
- Dementia
- Atrial fibrillation and hypertension
- Use of the 4th drug in the treatment of hypertension. The place of aldosterone antagonists and alpha-blockers
- The patient with pre-hypertension
20th European Meeting on Hypertension
June 18-21, 2010 – Oslo, Norway
Teaching Session 1
- Patient-centered genetics and genomics: Can we use it in clinical practice?
- Arterial Stiffness: what does it mean for our patients?
- Blood Pressure Should be Lowered <130/80 mmHg in High Risk Patients
- BP Targets (mmHg) by Treatment
Teaching Session 2
- How to Treat Hypertension in Children and Adolescents
- How to Treat Hypertensin in Elderly Patients?
- Benefits and Risks of Sports in Hypertensive Patients
Teaching Session 3
- Resistant hypertension: a difficult case
- Antithrombotic drugs and hypertension: Indication or contra-indication
- Components of the POLYPILL
- Control of BP in the Population Is the Polypill the solution?
19th European Meeting on Hypertension and Cardiovascular Protection
June 12-16, 2009 – Milan, Italy
Teaching Session 1 – Hypertension and other risk factors
- Diabetes and Hypertension
- Obesity and Hypertension
- Shall we continue using beta-blocking agents as first-line drugs in hypertension? Pro
- Shall we continue using beta-blocking agents as first-line drugs in hypertension? Con
Teaching Session 2 – Management of Hypertension
- When to start treatment of high blood pressure
- Specific renin inhibitors
- How to improve compliance to antihypertensive therapy
- Round Table – Introduction: Do we need new antihypertensive drugs?
Teaching Session 3 – Blood pressure measurement
Teaching Seminars 2009
The 18th Scientific Meeting of the European Society of Hypertension and the 22nd Scientific Meeting of the International Society of Hypertension
June 14-19, 2008 – Berlin, Germany
Teaching Seminar 1 – Risk factors and hypertension in daily practice
- When to look for genetic influences in hypertensives
- Risk factors in hypertension: should we give antiplatelet drugs to all hypertensives? Should we give statins to all hypertensives?
- Do we need new antihypertensive drugs?
Teaching Seminar 2 – Secondary hypertension
- Hyperaldosteronism: should we check it in all hypertensive patients? Arguments pro
- Diagnosis and management of hyperaldosteronism
- Angioplasty for atherosclerotic renovascular disease
- Pheochromocytoma
Teaching Seminar 3 – Treatment of hypertension in general and special conditions
- Treatment of HT in general and special conditions-about a difficult case
- Masked hypertension (isolated ambulatory hypertension)
- Hypertension in women – should they be treated differently?
XVII European Meeting on Hypertension
June 17-21, 2007 – Milan, Itlay
Teaching Seminar 1 – Special problems in hypertension
- Sex & the Heart
- Erectile dysfunction Therapeutic agents: Bad and Good
- Obstructive sleep apnea syndrome (SAS): shall we check on all hypertensive (HT) patients?
- Where is hypertension research going?
Teaching Seminar 2 – Organ damage in hypertension
- Left Ventricular Hypertrophy-Role of echocardiogram
- Organ damage in hypertension Left Ventricular Hypertrophy-Role of ECG
- Organ damage in hypertension: Retinal Vessels
- Hypertension and the kidney
- Organ damage in hypertension-Systemic arteries
Teaching Seminar 3 – Detection and screening in hypertension
- Home BP monitoring 2007 Guidelines
- Shall we measure an ABI in all Hypertensive patients?
- New approaches to interfere with the RAS system: are they applicable in clinical practice?
- Renin-angiotensin aldosterone system (RAAS) acting drugs-pharmacological update
XVI European Meeting on Hypertension
June 12-15, 2006 – Madrid, Spain
Teaching Seminar 1 – WorkGroup 8
- Identification of total CV risk in the clinical practice. The European Approach
- Identification of total CV risk in the clinical practice. The USA Approach
- Do new markers of risk fit into the clinical assessment strategy?
Teaching Seminar 4
- How often and under which conditions do we see MA?
- What has hypertension to do with microalbuminuria?
- Does MA stay or can we change it?
- Does it help the prognosis when we reduce MA?
Teaching Seminar 6
- Trial of preventing hypertension (TROPHY): findings and implications
- Early resistance artery changes in essential hypertension
- The role of small arteries in hypertensive target organ damage
- Transient prehypertensive treatment and the progression of hypertension
Teaching Seminar 10
- Omics and cardiovascular disease or pathwayomics and cardiovascular disease
- Hypertension trials: have we been doing the right thing?
- Intervention on new mechanisms
- Arterial hypertension and public health
XV European Meeting on Hypertension
June 17-21, 2005 – Milan, Italy
Teaching Seminar 1
- Diagnosis and management of cardiac arrhythmias
- Mild to severe renal damage. Implication for cardiovascular risk and treatment
- Resistant hypertension: definition and management
Teaching Seminar 2
Teaching Seminar 3